Pentetic Acid Excipient | Finished Formulations with Pentetic Acid Excipient | Pharmacompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
CDMO Prospector
- Demo Dashboard
Drugs in Dev.
News
Blog
Market Place
Login

Pentetic Acid Excipient
FDF Dossiers Suppliers

munit-sa-m-2025-04-14

Contact Supplier

Polpharma is a Polish CDMO of APIs and a significant European API producer, delivering products to companies worldwide.

Contact Supplier

SPI Pharma has been solving formulation challenges using superior functional materials.

Contact Supplier

Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

Contact Supplier

Suanfarma, at the Core of a Better Life.

Contact Supplier

xyz-pharma-m-2025-04-14

Contact Supplier

Pentetic Acid Excipient

FINISHED DOSAGE FORMULATIONS

FDF Dossiers Suppliers

FDF Dossiers Suppliers

PharmaCompass

Xls

Filters

Reset all filters

Filters

FILTER :

filter Drug Reset all filters

6 All

01 1KINEVAC

02 2MAGNEVIST

03 1OPDUALAG

04 1SINCALIDE

05 1ZEVALIN

filter Application Number Reset all filters

6 All

01 117697

02 119596

03 121037

04 1125019

05 1210850

06 1761234

filter Patent Reset all filters

6 All

01 5No

02 1Yes

List of Suppliers

01

BAYER HLTHCARE

Gadopentetate Dimeglumine

Pharma Live Expo

Not Confirmed

BAYER HLTHCARE

Pharma Live Expo

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

GADOPENTETATE DIMEGLUMINE

Drug : MAGNEVIST

Dosage Form : INJECTABLE; INJECTION

Application Number : 19596

Country : US

Patented : No

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

BAYER HLTHCARE

Gadopentetate Dimeglumine

Pharma Live Expo

Not Confirmed

BAYER HLTHCARE

Pharma Live Expo

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

GADOPENTETATE DIMEGLUMINE

Drug : MAGNEVIST

Dosage Form : INJECTABLE; INJECTION

Application Number : 21037

Country : US

Patented : No

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

03

BRACCO

Pharma Live Expo

Not Confirmed

BRACCO

Pharma Live Expo

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Drug : KINEVAC

Dosage Form : POWDER; INTRAVENOUS

Application Number : 17697

Country : US

Patented : No

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

04

BRISTOL MYERS SQUIBB

Nivolumab;Relatlimab-rmbw

Pharma Live Expo

Not Confirmed

BRISTOL MYERS SQUIBB

Pharma Live Expo

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

NIVOLUMAB; RELATLIMAB-RMBW

Drug : OPDUALAG

Dosage Form : SOLUTION; INTRAVENOUS

Application Number : 761234

Country : US

Patented : No

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

05

MAIA PHARMS INC

Pharma Live Expo

Not Confirmed

MAIA PHARMS INC

Pharma Live Expo

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Drug : SINCALIDE

Dosage Form : POWDER; INTRAVENOUS

Application Number : 210850

Country : US

Patented : Yes

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

06

SPECTRUM PHARMS

Ibritumomab Tiuxetan

Pharma Live Expo

Not Confirmed

SPECTRUM PHARMS

Pharma Live Expo

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

IBRITUMOMAB TIUXETAN

Drug : ZEVALIN

Dosage Form : INJECTABLE; INJECTION

Application Number : 125019

Country : US

Patented : No

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
Ask Us!